Isolation of Mycoplasma hominis in critically ill patients with pulmonary infections: clinical and microbiological analysis in an intensive care unit
Authors:
- Estibaliz UgaldeEUEstibaliz Ugalde
- Idoia MonteagudoIMIdoia Monteagudo
- Ana SaezASAna Saez
- Jesús AgüeroJAJesús Agüero
- JesúsJEJesús
- Luis Martinez-MartinezLMLuis Martinez-Martinez
- Eduardo MiñambresEMEduardo Miñambres
- 8 November 2006
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 33 (1) , 143-147
Abstract
Objective Mycoplasma hominis is a well recognized extragenital pathogen. However, it is an uncommon cause of respiratory infections in critically ill patients admitted to the intensive care unit (ICU). Design and setting Prospective clinical investigation in a 21-bed ICU in a university hospital. Patients Seven patients requiring intensive care who developed a ICU-acquired pneumonia in which M. hominis was recovered from bronchoalveolar lavage and pleural fluid cultures. Interventions M. hominis was isolated in all patients by use of conventional bacteriological cultures. All strains were identified by 16S rRNA gene sequencing analysis. Patients' charts were reviewed for each case of infection. Results Seven strains of M. hominis were isolated during a 4-year period. All of these isolates were recovered from adult men admitted to the ICU and all had clinical signs of pneumonia. In three patients treatment for M. hominis with quinolones was associated with a good clinical response. Conclusion Suspicion of M. hominis pneumonia must be heightened particularly in critically ill patients. Therefore an understanding of the microbiology of this organism is essential to successfully treat patients with these infections that are not ordinarily covered with standard antibiotic therapy.Keywords
This publication has 17 references indexed in Scilit:
- Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized studyIntensive Care Medicine, 2005
- Post-ICU mortality in critically ill infected patients: an international studyIntensive Care Medicine, 2005
- Post-ICU mortality in critically ill infected patients: an international studyIntensive Care Medicine, 2004
- Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severityIntensive Care Medicine, 2004
- Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia – Chicago, Illinois, May 2002Intensive Care Medicine, 2002
- Evaluation of BacT/ALERT System for Detection of Mycoplasma hominis in Simulated Blood CulturesJournal of Clinical Microbiology, 2001
- Susceptibilities of Mycoplasma hominis, M. pneumoniae , and Ureaplasma urealyticum to GAR-936, Dalfopristin, Dirithromycin, Evernimicin, Gatifloxacin, Linezolid, Moxifloxacin, Quinupristin-Dalfopristin, and Telithromycin Compared to Their Susceptibilities to Reference Macrolides, Tetracyclines, and QuinolonesAntimicrobial Agents and Chemotherapy, 2001
- Mycoplasma hominis Pneumonia Complicating Bilateral Lung TransplantationChest, 1997
- Extragenital Mycoplasma hominis Infections in Adults: Emphasis on ImmunosuppressionClinical Infectious Diseases, 1993
- Effect of blood culture media on the in vitro recovery of Mycoplasma hominisJournal of Infection, 1988